STRATEC Biomedical AG (SBS.DE)
XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
At close: 05:35PM CEST
| Previous close | 42.85 |
| Open | 42.45 |
| Bid | 42.45 x 3600 |
| Ask | 42.65 x 6200 |
| Day's range | 42.45 - 43.15 |
| 52-week range | 36.00 - 69.00 |
| Volume | |
| Avg. volume | 9,000 |
| Market cap | 516.626M |
| Beta (5Y monthly) | 0.13 |
| PE ratio (TTM) | 40.09 |
| EPS (TTM) | 1.06 |
| Earnings date | 26 Apr 2024 |
| Forward dividend & yield | 0.55 (1.28%) |
| Ex-dividend date | 20 May 2024 |
| 1y target est | 104.44 |
Simply Wall St.Unveiling 3 Leading Growth Companies In Germany With Up To 35% Insider Ownership
In recent weeks, Germany's market has shown signs of resilience, with the DAX index climbing 2.39%, reflecting a broader European uptick in business activity and investor confidence. In such an environment, growth companies with substantial insider ownership can be particularly compelling, as high insider stakes often align management’s interests with those of shareholders, potentially leading to more prudent and dedicated stewardship amidst fluctuating markets.
Simply Wall St.Should Weakness in Stratec SE's (ETR:SBS) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
It is hard to get excited after looking at Stratec's (ETR:SBS) recent performance, when its stock has declined 9.9...
- Simply Wall St.
Earnings Miss: Stratec SE Missed EPS By 24% And Analysts Are Revising Their Forecasts
Shareholders might have noticed that Stratec SE ( ETR:SBS ) filed its annual result this time last week. The early...
© 2024 Yahoo. All rights reserved.